US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Yojee Limited (YOJ) 銘柄情報

Yojee Limited (YOJ)

0.29

0.01

(3.57%)

終了 7月11日 3:00PM

Yojee Limited (YOJ) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.29

( 3.57% )

買値

0.275

売値

0.29

出来高

6,899

平均取引量 (3 か月)

AUD 110,393

財務取引量

-

0.29 日の範囲 0.29

0.23 52 週間の範囲 0.54

時価総額

企業価値

100.453M

前日終値

0.28

始値

0.29

時刻

最終取引時間

VWAP

-

歳入

545.03k

純利益

-6.8M

発行済株式数

355,453,511

浮動株比率 (%)

64.12%

機関投資家保有比率 (%)

16.62%

配当利回り

PER

-14.6

株価売上高倍率 (PSR)

195.65

1 株当たり利益 (EPS)

-0.02

ベータ

1.38

Yojee Limited, a logistics technology company, focuses on the freight operations. The company offers transport carrier management system platform, which enables logistics providers to consolidate supply chain networks into a single intuitive system. It also develops MOSAIC platform, a solution for f... Yojee Limited, a logistics technology company, focuses on the freight operations. The company offers transport carrier management system platform, which enables logistics providers to consolidate supply chain networks into a single intuitive system. It also develops MOSAIC platform, a solution for freight forwarders uniting teams and partners on a single collaborative system. The company is based in West Perth, Australia. 詳細を表示

セクター

Information Technology

業界

Software

ウェブサイト

yojee.com

本社

West Perth, Australia

設立

-

Yojee Limited is listed in the Information Technology sector of the オーストラリア証券取引所 with ticker YOJ. The last closing price for Yojee was AUD0.28. Over the last year, Yojee shares have traded in a share price range of AUD 0.23 to AUD 0.54.

Yojee currently has 355,453,511 shares in issue. The market capitalisation of Yojee is AUD103.08 million. Yojee has a price to earnings ratio (PE ratio) of -14.60.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.02	7.40740740741	0.27	0.3	0.27	29496	0.27883261	DE
4	0.02	7.40740740741	0.27	0.31	0.2375	69920	0.27288656	DE
12	0.025	9.43396226415	0.265	0.355	0.2375	111215	0.28569866	DE
26	-0.08	-21.6216216216	0.37	0.43	0.23	172468	0.30265487	DE
52	-0.16	-35.5555555556	0.45	0.54	0.23	233042	0.39371614	DE
156	0.271	1426.31578947	0.019	0.54	0.002	450666	0.11687156	DE
260	0.1	52.6315789474	0.19	0.54	0.002	639742	0.10941693	DE

YOJ - Frequently Asked Questions (FAQ)

What is the current Yojee Limited share price?

The current share price of Yojee Limited is AUD 0.29

How many Yojee Limited shares are in issue?

Yojee Limited has 355,453,511 shares in issue

What is the market cap of Yojee Limited?

The market capitalisation of Yojee Limited is AUD 103.08M

What is the 1 year trading range for Yojee Limited share price?

Yojee Limited has traded in the range of AUD 0.23 to AUD 0.54 during the past year

What is the PE ratio of Yojee Limited?

The price to earnings ratio of Yojee Limited is -14.6

What is the cash to sales ratio of Yojee Limited?

The cash to sales ratio of Yojee Limited is 195.65

What is the registered address of Yojee Limited?

The registered address for Yojee Limited is Ground Floor, West Perth, Western Australia, 6005

What is the Yojee Limited website address?

The website address for Yojee Limited is yojee.com

Which industry sector does Yojee Limited operate in?

Yojee Limited operates in the Software sector

rosemountbomber

rosemountbomber 14分前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 17分前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

BahamaPete

BahamaPete 26分前

Thanks OCKHAM's RAZOR, I added your links to my DD post. Go $TKOI

Helter Skelter

Helter Skelter 35分前

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

Twiggs333

Twiggs333 42分前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Popeye 42分前

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 44分前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 48分前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 56分前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 1時間前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Real McCoy

Real McCoy 1時間前

Well yeah this one has the most lies.

3rd attempt: you ok with lies, yes or no?

pos_stock_hoarder

pos_stock_hoarder 1時間前

New York Dolls - Looking for a Kiss

https://youtu.be/GvmvMFXWzc8

Genz2

Genz2 1時間前

https://techcrunch.com/2026/07/10/us-cyber-agency-cisa-had-to-build-its-incident-playbook-during-the-incident-agency-reveals/

According to Krebs, the researcher tried to alert the contractor but didn’t hear back. Only after Krebs contacted CISA did the agency take the repository offli

boston127

boston127 1時間前

Hey,

Thanks for the links you sent me. My PC blocked all of the URLs due to malware protection. I'm still in GNIS and the other one. I was up but they have dive bombed quite rapidly. Now, in the RED. Both companies are interesting.

LTR

I have an idea AF may turn up in discovery when the dots are lined up and connected. AF may look to be a witness in order to avoid being a defendent.

conix

conix 1時間前

Non-promotional information until there is a press release is a wise move.

CatfishHunter

CatfishHunter 1時間前

We should have news of next step well before years end. Vivos is already approved by FDA to start the EFS. Mayo Clinic needs to review and sign off on the approved conditions for the IRB and that’s just a formality. EFS could start as early as August. And 30 day patient status report about 45 days a

Philosophical Trader

Philosophical Trader 1時間前

How is this doing? This was a great runner with a 2 year cup and handle.

nwtf

nwtf 1時間前

You really dont have a clue what you are talking about. Just stop.

Cardiff Auto Receivables...

Native Mineral Resources

LYXOR IBEX 35 DR UCITS E...

iShares 7-10 Year Treasu...

Iervolino Entertainment

China Bluechemical (PK)

Global Ecology (EM)

Unicaja Banco (PK)

Xtrackers II USD Overnig...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。